Characterization of Scavengers of γ-Ketoaldehydes That Do Not Inhibit Prostaglandin Biosynthesis
Authors:
- 31 December 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 23 (1) , 240-250
Abstract
Expression of cyclooxygenase-2 (COX-2) is associated with the development of many pathologic conditions. The product of COX-2, prostaglandin H2 (PGH2), can spontaneously rearrange to form reactive γ-ketoaldehydes called levuglandins (LGs). This γ-ketoaldehyde structure confers a high degree of reactivity on the LGs, which rapidly form covalent adducts with primary amines of protein residues. Formation of LG adducts of proteins has been demonstrated in pathologic conditions (e.g., increased levels in the hippocampus in Alzheimer’s disease) and during physiologic function (platelet activation). On the basis of knowledge that lipid modification of proteins is known to cause their translocation and to alter their function, we hypothesize that modification of proteins by LG could have functional consequences. Testing this hypothesis requires an experimental approach that discriminates between the effects of protein modification by LG and the effects of cyclooxygenase-derived prostanoids acting through their G-protein coupled receptors. To achieve this goal, we have synthesized and evaluated a series of scavengers that react with LG with a potency more than 2 orders of magnitude greater than that with the ε-amine of lysine. A subset of these scavengers are shown to block the formation of LG adducts of proteins in cells without inhibiting the catalytic activity of the cyclooxygenases. Ten of these selective scavengers did not produce cytotoxicity. These results demonstrate that small molecules can scavenge LGs in cells without interfering with the formation of prostaglandins. They also provide a working hypothesis for the development of pharmacologic agents that could be used in experimental animals in vivo to assess the pathophysiological contribution of levuglandins in diseases associated with cyclooxygenase up-regulation.Keywords
This publication has 36 references indexed in Scilit:
- NSAIDs and breast cancer: a possible prevention and treatment strategyInternational Journal Of Clinical Practice, 2008
- Cyclooxygenases, prostanoids, and tumor progressionCancer and Metastasis Reviews, 2007
- NSAIDs and Cancer Prevention: Targets Downstream of COX-2Annual Review of Medicine, 2007
- Pyridoxamine Analogues Scavenge Lipid-Derived γ-Ketoaldehydes and Protect against H2O2-Mediated CytotoxicityBiochemistry, 2006
- Characterization of Bis(levuglandinyl) Urea Derivatives as Products of the Reaction between Prostaglandin H2 and ArginineBiochemistry, 2004
- A Population-Based Study of Daily Nonsteroidal Anti-inflammatory Drug Use and Prostate CancerMayo Clinic Proceedings, 2002
- Generation of pyrroles in the reaction of Levuglandin E2 with proteinsThe Journal of Organic Chemistry, 1994
- Chemical synthesis of stereospecifically labeled pyridoxamine 5'-phosphateThe Journal of Organic Chemistry, 1991
- On the Formation of Isopropylidenepyridoxines. A Convenient Method for the Preparation of 2,2,8-Trimethyl-4H-1,3-dioxino[4,5-c]pyridin-5-ylmethanol from Pyridoxine Hydrochloride.Acta Chemica Scandinavica, 1989
- Prostaglandin endoperoxide reaction mechanisms and the discovery of levuglandinsAccounts of Chemical Research, 1985